Royalty payments and Canada's Access to Medicines Regime

A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2020-09-17

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data